These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2142968)

  • 21. Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche.
    Lucky AW; Rosenfield RL; McGuire J; Rudy S; Helke J
    J Clin Endocrinol Metab; 1986 May; 62(5):840-8. PubMed ID: 3007557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of cyproterone acetate on rate of hair growth in hirsute females.
    Jones KR; Katz M; Keyzer C; Gordon W
    Br J Dermatol; 1981 Dec; 105(6):685-92. PubMed ID: 6459114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cyproterone acetate and spironolactone compared in the therapy of female hirsutism].
    Suraci C; Costa C; De Pedrini P
    Clin Ter; 1983 Mar; 104(6):463-7. PubMed ID: 6221860
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism.
    Sahin Y; Bayram F; Keleştimur F; Müderris I
    J Endocrinol Invest; 1998 Jun; 21(6):348-52. PubMed ID: 9699125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the cyproterone acetate + ethynil oestradiol antiandrogen association on blood coagulation and fibrinolysis in hirsute women.
    Ghezzo F; Manieri C; Rodi R; Messina M; Molinatti GM
    Panminerva Med; 1981; 23(4):223-6. PubMed ID: 6212899
    [No Abstract]   [Full Text] [Related]  

  • 26. Female hirsutism: pathophysiological considerations and therapeutic implications.
    Biffignandi P; Massucchetti C; Molinatti GM
    Endocr Rev; 1984; 5(4):498-513. PubMed ID: 6094172
    [No Abstract]   [Full Text] [Related]  

  • 27. Cyproterone acetate treatment of females with hyperandrogenism.
    Julesz J; Faredin I; Tóth I; László FA
    Endokrinologie; 1981 Dec; 78(2-3):168-74. PubMed ID: 6460612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyproterone acetate versus hydrocortisone treatment in late-onset adrenal hyperplasia.
    Spritzer P; Billaud L; Thalabard JC; Birman P; Mowszowicz I; Raux-Demay MC; Clair F; Kuttenn F; Mauvais-Jarvis P
    J Clin Endocrinol Metab; 1990 Mar; 70(3):642-6. PubMed ID: 2137832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiandrogens and hirsutism.
    Biffignandi P; Molinatti GM
    Horm Res; 1987; 28(2-4):242-9. PubMed ID: 2969862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Long-term treatment of virilized women with cyproterone acetate (author's transl)].
    Abrahamsson L; Hackl H; Lindström B; Sogn J
    Wien Klin Wochenschr; 1981 Sep; 93(17):552-6. PubMed ID: 6458162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cyproterone acetate on glucocorticoid secretion in patients treated for hirsutism.
    Holdaway IM; Croxson MS; Evans MC; France J; Sheehan A; Wilson T; Ibbertson HK
    Acta Endocrinol (Copenh); 1983 Oct; 104(2):222-6. PubMed ID: 6227191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Differential use of cyproterone acetate in androgen manifestations in the female].
    Kaiser E
    Arch Gynecol Obstet; 1989; 245(1-4):985-6. PubMed ID: 2529830
    [No Abstract]   [Full Text] [Related]  

  • 33. Late-onset congenital adrenal hyperplasia in women with hirsutism.
    Arnaout MA
    Eur J Clin Invest; 1992 Oct; 22(10):651-8. PubMed ID: 1333959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late-onset adrenal steroid 3 beta-hydroxysteroid dehydrogenase deficiency. I. A cause of hirsutism in pubertal and postpubertal women.
    Pang SY; Lerner AJ; Stoner E; Levine LS; Oberfield SE; Engel I; New MI
    J Clin Endocrinol Metab; 1985 Mar; 60(3):428-39. PubMed ID: 2982896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gonadotrophin-releasing hormone agonist therapy for hirsutism is as effective as high dose cyproterone acetate but results in a longer remission.
    Carmina E; Lobo RA
    Hum Reprod; 1997 Apr; 12(4):663-6. PubMed ID: 9159420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of flutamide and cyproterone acetate in the treatment of hirsutism: a randomized controlled trial.
    Grigoriou O; Papadias C; Konidaris S; Antoniou G; Karakitsos P; Giannikos L
    Gynecol Endocrinol; 1996 Apr; 10(2):119-23. PubMed ID: 8701785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism.
    Sahin Y; Dilber S; Keleştimur F
    Fertil Steril; 2001 Mar; 75(3):496-500. PubMed ID: 11239530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of hirsutism with cyproterone acetate and percutaneous estradiol].
    Rigaud C; Vincens M; Giacomini P; Kuttenn F; Mauvais-Jarvis P
    Presse Med; 1983 Jan; 12(2):73-6. PubMed ID: 6221318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of anti-androgens in the treatment of hirsutism.
    McKenna TJ
    Clin Endocrinol (Oxf); 1991 Jul; 35(1):1-3. PubMed ID: 1832345
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of hirsutism by oral cyproterone acetate and percutaneous estradiol.
    Kuttenn F; Rigaud C; Wright F; Mauvais-Jarvis P
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1107-11. PubMed ID: 6448264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.